Researchers Excited About 100% Cancer Cure with Experimental Drug
Even though it was a small study of only 19 participants suffering from rectal cancer, researchers are optimistic about an experimental cancer drug called dostarlimab, which allowed the patient’s own immune system to target and distort cancer cells.
